Federated Hermes Inc. boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 25.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 339,063 shares of the biotechnology company’s stock after acquiring an additional 69,567 shares during the quarter. Federated Hermes Inc.’s holdings in Axon Enterprise were worth $201,514,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in AXON. New Wave Wealth Advisors LLC purchased a new stake in Axon Enterprise during the 4th quarter worth $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise in the fourth quarter worth about $45,000. Prestige Wealth Management Group LLC boosted its holdings in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the last quarter. Stonebridge Financial Group LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at approximately $53,000. Finally, GPS Wealth Strategies Group LLC increased its holdings in Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after purchasing an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Axon Enterprise Stock Performance
Shares of AXON opened at $497.13 on Friday. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The firm has a market capitalization of $38.09 billion, a PE ratio of 128.46, a P/E/G ratio of 5.17 and a beta of 1.13. The firm has a 50-day moving average price of $582.26 and a 200 day moving average price of $554.66. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.
Analyst Ratings Changes
Check Out Our Latest Report on Axon Enterprise
Insider Activity
In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 6.10% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.